These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38619498)

  • 1. A review of the mesotheliogenic potency of cleavage fragments found in talc.
    Miller E; Beckett EM; Cheatham D; Comerford CE; Lewis RC; Krevanko C; Mandava N; Pierce JS
    Toxicol Ind Health; 2024 Jul; 40(7):398-424. PubMed ID: 38619498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
    Gamble JF; Gibbs GW
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tremolite asbestos exposures associated with the use of commercial products.
    Finley BL; Pierce JS; Phelka AD; Adams RE; Paustenbach DJ; Thuett KA; Barlow CA
    Crit Rev Toxicol; 2012 Feb; 42(2):119-46. PubMed ID: 22141364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant mesothelioma following repeated exposures to cosmetic talc: A case series of 75 patients.
    Emory TS; Maddox JC; Kradin RL
    Am J Ind Med; 2020 Jun; 63(6):484-489. PubMed ID: 32175619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibers in lung tissues of mesothelioma cases among miners and millers of the township of Asbestos, Quebec.
    Dufresne A; Harrigan M; Massé S; Bégin R
    Am J Ind Med; 1995 Apr; 27(4):581-92. PubMed ID: 7793429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the presence of asbestos in cosmetic talcum products.
    Pierce JS; Riordan AS; Miller EW; Gaffney SH; Hollins DM
    Inhal Toxicol; 2017 Aug; 29(10):443-456. PubMed ID: 29124998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthophyllite asbestos: state of the science review.
    Gaffney SH; Grespin M; Garnick L; Drechsel DA; Hazan R; Paustenbach DJ; Simmons BD
    J Appl Toxicol; 2017 Jan; 37(1):38-49. PubMed ID: 27397058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans.
    Garabrant DH; Pastula ST
    Toxicol Appl Pharmacol; 2018 Dec; 361():127-136. PubMed ID: 30077661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tremolite and mesothelioma.
    Roggli VL; Vollmer RT; Butnor KJ; Sporn TA
    Ann Occup Hyg; 2002 Jul; 46(5):447-53. PubMed ID: 12176759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant mesothelioma in a patient with anthophyllite asbestos fibres in the lungs.
    Phillips JI; Murray J
    Ann Occup Hyg; 2010 Jun; 54(4):412-6. PubMed ID: 20427324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serous Ovarian Cancer Caused by Exposure to Asbestos and Fibrous Talc in Cosmetic Talc Powders-A Case Series.
    Steffen JE; Tran T; Yimam M; Clancy KM; Bird TB; Rigler M; Longo W; Egilman DS
    J Occup Environ Med; 2020 Feb; 62(2):e65-e77. PubMed ID: 31868762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elongated particulate burden in an individual who died of mesothelioma and had an occupational history as a talc "mucker".
    Dodson RF; Moline J; Salinas CD; Poye LW
    Inhal Toxicol; 2024 Mar; 36(3):205-216. PubMed ID: 38502172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant mesothelioma incidence among talc miners and millers in New York State.
    Finkelstein MM
    Am J Ind Med; 2012 Oct; 55(10):863-8. PubMed ID: 22544543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling mesothelioma risk factors from amphibole fiber dimensionality: mineralogical and epidemiological perspective.
    Wylie AG; Korchevskiy A; Segrave AM; Duane A
    J Appl Toxicol; 2020 Apr; 40(4):515-524. PubMed ID: 32040984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asbestos-related disease associated with exposure to asbestiform tremolite.
    Srebro SH; Roggli VL
    Am J Ind Med; 1994 Dec; 26(6):809-19. PubMed ID: 7892832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent homozygous deletion of Cdkn2a/2b in tremolite-induced malignant mesothelioma in rats.
    Okazaki Y; Misawa N; Akatsuka S; Kohyama N; Sekido Y; Takahashi T; Toyokuni S
    Cancer Sci; 2020 Apr; 111(4):1180-1192. PubMed ID: 32080953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of asbestos exposure resulting from simulated application of spiked talcum powders.
    Miller EW; Roberts B; Keeton K; Monnot A; Tarpey T; Zoghby N; Segrave A; Pierce JS
    Inhal Toxicol; 2022; 34(13-14):380-398. PubMed ID: 36227690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():49-73. PubMed ID: 18686078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An updated review of diffuse mesothelioma of the pleura - A sentinel health event of potential elongate mineral particle pathogenicity.
    Smith SR
    Environ Res; 2023 Aug; 230():115608. PubMed ID: 36965792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency and severity of pleural changes in former workers exposed to anthophyllite associated with other contaminating amphibole asbestos in Brazil.
    Macedo RF; Cerqueira EMFP; Algranti E; Silva D; De Capitani EM
    Am J Ind Med; 2019 Jun; 62(6):503-510. PubMed ID: 31046142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.